Back
Fortress Biotech Quote, Financials, Valuation and Earnings
Sponsored
FBIO
Sponsored
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
31
FBIO
Fortress Biotech
Last Price:
1.85
Seasonality Move:
-21.79%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Fortress Biotech Price Quote
$1.85
-0.08 (-4.15%)
(Updated: September 19, 2024 at 6:55 PM ET)
Fortress Biotech Key Stats
Sell
31
Fortress Biotech (FBIO)
is a Sell
Day range:
$1.89 - $2.04
52-week range:
$1.24 - $5.29
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.21
P/B ratio:
2.46%
Volume:
230.4K
Avg. volume:
237.2K
1-year change:
-62.71%
Market cap:
$44M
Revenue:
$84.5M
EPS:
$-13.45
How Much Does Fortress Biotech Make?
-
How Much Are Fortress Biotech's Sales Annually?
FBIO Revenues are $84.5M -
How Much Profit Does Fortress Biotech's Make A Year?
FBIO net income is -$60.6M
Is Fortress Biotech Growing As A Company?
-
What Is Fortress Biotech's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.14% -
What Is Fortress Biotech's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Fortress Biotech Stock Price Performance
-
Did Fortress Biotech Stock Go Up Last Month?
Fortress Biotech share price went up by 3.76% last month -
Did FBIO's Share Price Rise Over The Last Year?
FBIO share price fell by -62.71% over the past 1 year
What Is Fortress Biotech 52-Week High & Low?
-
What Is Fortress Biotech’s 52-Week High Share Price?
Fortress Biotech has traded as high as $5.29 over the past 52 weeks -
What Is Fortress Biotech’s 52-Week Low Share Price?
Fortress Biotech has traded as low as $1.24 over the past 52 weeks
Fortress Biotech Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Fortress Biotech?
-
How Much Debt Does Fortress Biotech Have?
Total long term debt quarterly is $70M -
How Much Cash Does Fortress Biotech Have?
Cash and short term investments quarterly total is $76.2M -
What Is Fortress Biotech’s Book Value Per Share?
Book value per share is 0.79
Is Fortress Biotech Cash Flow Positive?
-
What Is FBIO Cash Flow From Operations?
Cash flow from operations (TTM) is -$98.9M -
What Is Fortress Biotech’s Cash Flow From Financing?
Cash flow from financing (TTM) is $83.1M -
What Is Fortress Biotech’s Cash Flow From Investing?
Cash flow from investing (TTM) is $4.9M
Fortress Biotech Return On Invested Capital
-
Is Management Doing A Good Job?
FBIO return on invested capital is -78.24% -
What Is Fortress Biotech Return On Assets?
ROA measures how assets are converting to revenues and is -25.14% -
What Is FBIO Return On Equity?
ROE is a measure of profitability and is 0%
Fortress Biotech Earnings Date & Stock Price
-
What Is Fortress Biotech's Stock Price Today?
A single share of FBIO can be purchased today for 1.93 -
What Is Fortress Biotech’s Stock Symbol?
Fortress Biotech trades on the nasdaq under the ticker symbol: FBIO -
When Is Fortress Biotech’s Next Earnings Date?
The next quarterly earnings date for Fortress Biotech is scheduled on November 7, 2024 -
When Is FBIO's next ex-dividend date?
Fortress Biotech's next ex-dividend date is September 20, 2024 -
How To Buy Fortress Biotech Stock?
You can buy Fortress Biotech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Fortress Biotech Competitors
-
Who Are Fortress Biotech's Competitors?
Below is a list of companies who compete with Fortress Biotech or are related in some way:
Fortress Biotech Dividend Yield
-
What Is FBIO Dividend Yield?
Fortress Biotech’s dividend yield currently is 0% -
What Is Fortress Biotech’s Payout Ratio?
Fortress Biotech’s payout ratio is -21.5% -
When Did Fortress Biotech Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Fortress Biotech’s Dividend Per Share?
Fortress Biotech pays a dividend of $0.00 per share
Fortress Biotech Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | -14.32% | 0.83% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 14.00 |
Upside from Last Price: | 625.39% |